Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Business intelligence is crucial in the decision-making process of
pharmaceutical and biopharmaceutical companies as they increase their levels
of external development and manufacturing. It also is vitally important for
contract service providers in evaluating their competitive advantage. Nice
Insight’s data facilitates that knowledge for the players in pharmaceutical
outsourcing. At Pharmaceutical Technology, we also use their research to
spot and track the trends we write about."
Michelle Hoffman Editorial Director,Pharmaceutical Drug Development and Manufacturing Group, Advanstar Pharmaceutical  
Pharma Chem Outsourcing 2013
September 16-18 Long Branch, NJ |
Albemarle Corporation BASF Chempacific Corporation Dottikon Exclusive Synthesis FutureFuel Haupt Pharma AG Monument Chemical PennAKem LLC Jubilant Chemsys
Jubilant Chemsys, a part of Jubilant Drug Discovery and Development Services under the flagship of Jubilant Life Science Limited, offers services in synthetic organic and medicinal chemistry to various pharmaceutical and biotechnology companies. Supported by a platform of confidentiality and intellectual property protection, services are designed to assist our customers to meet cost effectiveness and efficiency. The company’s scientific team is supported by strong infrastructure to facilitate complex syntheses at small and large scale, and address SAR needs for Medicinal Chemistry programs. http://www.jchemsys.com/
Regions
Asia, Europe Stock Symbol Private Filter of Jubilant Chemsys's services per Nice Insight Categories
Contact Jubilant Chemsys 
|
|
|
